3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
13
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
4
Lymphoid
3
Thoracic
1
Sarcoma
1
Other hematologic neoplasm
1
CNS
1
Conditions
Leukemia
183
Precursor Cell Lymphoblastic Leukemia-Lymphoma
130
Leukemia, Myeloid, Acute
95
Leukemia, Lymphocytic, Chronic, B-Cell
56
Lymphoma
53
Congenital Abnormalities
42
Burkitt Lymphoma
41
Myelodysplastic Syndromes
32
Leukemia, Myelomonocytic, Acute
30
Leukemia, Monocytic, Acute
30
Leukemia, Megakaryoblastic, Acute
29
Lymphoma, Non-Hodgkin
28
Leukemia, Erythroblastic, Acute
28
Lymphoma, Follicular
25
Leukemia, Biphenotypic, Acute
25
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
24
Lymphoma, Large B-Cell, Diffuse
24
Lymphoma, B-Cell, Marginal Zone
23
Lymphoma, Mantle-Cell
19
Lymphoma, Large-Cell, Immunoblastic
19
Leukemia, Myelomonocytic, Chronic
19
Leukemia, Myeloid, Chronic-Phase
19
Hematologic Neoplasms
19
Hodgkin Disease
17
Leukemia, Myelomonocytic, Juvenile
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
16
Waldenstrom Macroglobulinemia
15
Myeloproliferative Disorders
14
Lymphoma, Large-Cell, Anaplastic
14
Dendritic Cell Sarcoma, Interdigitating
13
Interventions
hydrocortisone hemisuccinate
1
Vincristine
1
Razoxane
1
Radiotherapy
1
Prednisone
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Hydrocortisone
1
Doxorubicin
1
Dexrazoxane
1
Cytarabine
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Cardiotoxicity
×
Other hematologic neoplasm
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled